Blog

April 15, 2024

1st April Newsletter

Featured Portfolio

An advanced device for direct visual rhizotomy, featuring a tubular sheath with specialized features including cut-aways and an integrated endoscope camera for enhanced precision.

TOP STORIES
PATENTS AND TECHNOLOGY

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

by Yahoo Finance in April ‘24
The RENASYS EDGE System is designed for patients suffering from these wounds and living at home. Chronic wounds, including ulcers, have a huge impact on a patient’s life beyond just the pain and discomfort, with 68% often becoming self-conscious of their wound and many becoming isolated.

Why Bayer is fighting so hard for Xarelto

by Juve Patent in April ‘24
The need for pharmaceutical company Bayer to restructure is discussed almost daily, with blockbuster drug Xarelto at the heart of the debate.

TOP STORIES
HEALTHCARE TRANSACTIONS

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™

by EIN News in April ‘24 

Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that on March 28, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) has set aside the injunction that was issued in August 2022 in the lawsuit filed by United Therapeutics (UTHR) in Case No. 1:20-cv-00755-RGA

 

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

by Devdiscourse in April ‘24 

It sued Teva and Mylan, which is now part of Viatris, for patent infringement over their proposed generic versions of the drug in 2018 and 2019, respectively

Cardiex Completes HEARTsense Wearable Study and Secures US Wearable Patent

by Investing News Network in April ‘24 

CARDIEX Limited (ASX:CDX) (CARDIEX, the Company) is pleased to announce the successful completion of two significant milestones in the commercialization of its wearable biomarker technology.

RECENTLY
ISSUED PATENTS

electroCore Expands Intellectual Property Portfolio

by GlobeNewswire in April ‘24

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO). 

 

Protenus Granted Two New Patents for Healthcare Compliance

by AccessWire in April ‘24

New patents granted for Patient Privacy Monitoring to expand technology used to monitor access to patient data that helps hospitals to identify patient record breaches.

CURRENT PORTFOLIO AVAILABLE FOR SALE
AND LICENSE WITH HIGH INTEREST

Fansmit is a platform that makes changing your television announcer as easy as changing your TV channel. The platform empowers consumers to provide personalized commentary on their favorite events (live or pre-recorded) using their connected devices, in lieu of otherwise ordinary network-provided commentary.  Leveraging its patented technology (two issued patents to date), Fansmit synchronizes those “fansmissions” to the event in real time, enabling other fans to listen to the alternative broadcast on their preferred connected device, creating an altogether different and superior fan experience. 
 
Newsletter
About peter

Created with Visual Composer